China Pharma Holding (STU:XQJ0) Buildings And Improvements : €8.48 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Buildings And Improvements?

China Pharma Holding's quarterly buildings and improvements declined from Sep. 2023 (€8.54 Mil) to Dec. 2023 (€8.47 Mil) but then increased from Dec. 2023 (€8.47 Mil) to Mar. 2024 (€8.48 Mil).

China Pharma Holding's annual buildings and improvements declined from Dec. 2021 (€9.08 Mil) to Dec. 2022 (€8.87 Mil) and declined from Dec. 2022 (€8.87 Mil) to Dec. 2023 (€8.47 Mil).

China Pharma Holding Buildings And Improvements Historical Data

The historical data trend for China Pharma Holding's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Buildings And Improvements Chart

China Pharma Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

8.44

8.24

9.08

8.87

8.47

China Pharma Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															8.89	8.36	8.54	8.47	8.48

China Pharma Holding Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines